Multiplikator Forward P/S: Dynatronics Corp (DYNT)

Dynatronics - logo grafis emiten DYNT

The forward P/S of Dynatronics Corporation (DYNT) reflects market confidence, with the metric holding at 0.00. This optimism is driven by the availability of comprehensive rehabilitation solutions and a streamlined distribution network. Partnerships with hospitals and sports medicine centers continue to support growth. Planned plant capacity utilization and the implementation of automated quality control systems ensure fundamental stability.

Dynatronics - Kapitalisasi marang prakiraan pendapatan DYNT (periode 04.07.2022 - 04.08.2024)

Ringkesan rincian data analitis dynatronics.com (DYNT)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:DYNT (Dynatronics Corp.)
Sampel barang dynatronics.com

Investors assess asset quality through market capitalization dynamics relative to projected revenue, where an upward trend in the expected P/S ratio confirms growing confidence in future earnings. For Dynatronics Corporation (DYNT), this metric reflects business resilience within the rehabilitation equipment niche, where moderate operating leverage and cost control render the valuation less volatile amid stable scalability.

Karo sapa Dynatronics Corporation saingan

Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD Inc. - Rasio rega marang pendapatan sing dikarepake|ZJYL: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan VANI|Multiplikator forward rega marang pendapatan XTNT|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeuroOne NMTC|Rasio rega marang prakiraan pendapatan Modular Medical (MODD)|Myomo Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S COCH (Envoy Medical, Inc.)|Multiplikator Forward P/S vivoslife.com VVOS|NVNO: Multiplikator forward rega marang pendapatan|Sintx Technologies - Rasio rega marang pendapatan sing dikarepake|Tenon Medical, Inc (TNON) - Rasio rega marang prakiraan pendapatan|Lifeward Ltd. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Autonomix Medical Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep invobioscience.com IVF|Rasio rega marang prakiraan pendapatan Bone Biologics Corp (BBLG)|Axonics Inc. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S BIOL (Biolase, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Paragon 28 Inc. (FNA)|INVO Bio - Multiplikator Forward P/S